M E D I A G N O S T
Mediagnost, founded in 1985, is dedicated to the research and manufacture of diagnostic test systems and has evolved into a modern and innovative enterprise whose products and diagnostic tools are marketed across the globe.
Mediagnost moved to the “Technology Park Tübingen-Reutlingen” in the year 2000. On these expansive new premises, Mediagnost has established state-of-the-art labs that are essential for excellence in production and research. The laboratories have been certified by the relevant German authorities, and our research and development objectives are conform with German laws relating to human pathogens and genetic engineering.
The manufacturing processes of our diagnostic products fulfill the requirements of the European Directive 98/79/EC. Therefore Mediagnost established a quality management system which is certified by a notified body according to ISO 13485.
The company’s affiliation with the University of Tuebingen and several other scientific institutions, as well as with the research departments of pharmaceutical companies, is conducive to the swift transfer of innovative technologies from the science lab directly to the customer. This cooperation, coupled with Mediagnost’s resources, will ensure that the company remains on the cutting edge of new technologies.
It is a great challenge for us to be involved in research aimed at designing diagnostic tools that offer greater efficiency and sensitivity. In this way we strive to meet the demands of our customers and provide optimal, individual solutions. Our clientele ranges from medical practitioners to clinical laboratories and research departments. In addition, Mediagnost customizes raw material for the requirements of the pharmaceutical industry.
The entire range of Mediagnost products enjoys international acclaim.
Anti-SARS-CoV-2 Antibody ELISA
Mediagnost Anti-SARS-CoV-2 ELISA is a highly specific Enzyme Immuno***** for the detection of IgG antibodies directed against SARS-CoV-2-S1 Receptor Binding Domain (RBD) in human blood.
Anti-SARS-CoV-2 IgG ELISA
Product Number E111-IVD
Regulatory Status in (EU) IVD
Reference material Not available
Incubation time 2.7 h
Antigen Eukaryotic expressed SARS-CoV-2-S1 Receptor Binding Domain (RBD)
Positive Control Positive Control Serum
Negative Control Negative Control Serum
Sample matrix Serum / Plasma
Sample dilution 1:201
Price 490 € , net, + Shipping Costs
Anti-SARS-CoV-2 IgG ELISA
Acid-labile Subunit human
Antibody and -conjugates
Coxsackievirus B3 Antibody
Growth Hormone human
Growth Hormone Mouse/Rat
HAV Antibody ELISA
HAV Antigen ELISA
Pseudomonas aeruginosa IgG
SARS-CoV-2 realDETECT Kit 250 Rxn